Fowkes FG - Search Results

1

Haemostatic and rheological factors in intermittent claudication: the influence of smoking and extent of arterial disease.

Lee AJ, Fowkes FG, Rattray A, Rumley A, Lowe GD. Lee AJ, et al. Among authors: fowkes fg. Br J Haematol. 1996 Jan;92(1):226-30. doi: 10.1046/j.1365-2141.1996.00283.x. Br J Haematol. 1996. PMID: 8562400 Clinical Trial.

2

Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease.

Fowkes FG, Anandan CL, Lee AJ, Smith FB, Tzoulaki I, Rumley A, Powell JT, Lowe GD. Fowkes FG, et al. J Vasc Surg. 2006 Mar;43(3):474-80. doi: 10.1016/j.jvs.2005.11.018. J Vasc Surg. 2006. PMID: 16520158 Free article.

3

Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study.

Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Tzoulaki I, et al. Among authors: fowkes fg. Eur Heart J. 2007 Feb;28(3):354-62. doi: 10.1093/eurheartj/ehl441. Epub 2007 Jan 9. Eur Heart J. 2007. PMID: 17213229

4

Risk factor profile of nonsmokers with peripheral arterial disease.

Fowkes FG, Dunbar JT, Lee AJ. Fowkes FG, et al. Angiology. 1995 Aug;46(8):657-62. doi: 10.1177/000331979504600803. Angiology. 1995. PMID: 7639411

5

Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease.

Smith FB, Lee AJ, Rumley A, Fowkes FG, Lowe GD. Smith FB, et al. Among authors: fowkes fg. Atherosclerosis. 1995 May;115(1):35-43. doi: 10.1016/0021-9150(94)05498-8. Atherosclerosis. 1995. PMID: 7669086

6

Relationship between plasma essential fatty acids and smoking, serum lipids, blood pressure and haemostatic and rheological factors.

Leng GC, Smith FB, Fowkes FG, Horrobin DF, Ells K, Morse-Fisher N, Lowe GD. Leng GC, et al. Among authors: fowkes fg. Prostaglandins Leukot Essent Fatty Acids. 1994 Aug;51(2):101-8. doi: 10.1016/0952-3278(94)90085-x. Prostaglandins Leukot Essent Fatty Acids. 1994. PMID: 7972262

7

Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease.

Fowkes FG, Lowe GD, Housley E, Rattray A, Rumley A, Elton RA, MacGregor IR, Dawes J. Fowkes FG, et al. Lancet. 1993 Jul 10;342(8863):84-6. doi: 10.1016/0140-6736(93)91288-w. Lancet. 1993. PMID: 8100915

8

Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease.

Smith FB, Lowe GD, Fowkes FG, Rumley A, Rumley AG, Donnan PT, Housley E. Smith FB, et al. Among authors: fowkes fg. Atherosclerosis. 1993 Sep;102(2):155-62. doi: 10.1016/0021-9150(93)90157-p. Atherosclerosis. 1993. PMID: 8251001

9

Fibrin D-dimer, haemostatic factors and peripheral arterial disease.

Lee AJ, Fowkes FG, Lowe GD, Rumley A. Lee AJ, et al. Among authors: fowkes fg. Thromb Haemost. 1995 Sep;74(3):828-32. Thromb Haemost. 1995. PMID: 8571305 Clinical Trial.

10

Variation in cardiovascular risk factors by angiographic site of lower limb atherosclerosis.

Smith FB, Lee AJ, Fowkes FG, Lowe GD, Rumley A. Smith FB, et al. Among authors: fowkes fg. Eur J Vasc Endovasc Surg. 1996 Apr;11(3):340-6. doi: 10.1016/s1078-5884(96)80082-7. Eur J Vasc Endovasc Surg. 1996. PMID: 8601246 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters